Clinical Study

A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy

Table 2

Surgical procedures and outcomes of participants with or without conbercept pretreatment.

Preoperative intravitreal conbercept ()Control () value

Severity of intraoperative bleeding grade0.002
 3310
 21022
 12714
 0147
Recurrent VH
 ≤4 weeks9 (16.67%)26 (49.05%)0.000
  Severity of recurrent VH grade0.000
   401
   302
   228
   1715
 >4 weeks6 (11.11%)8 (15.01%)0.973
  Severity of recurrent VH grade0.732
   400
   301
   223
   144

VH: vitreous hemorrhage.